Monthly Archives: July 2015

The Global Biosensors Market Will Be Valued At US$23 Billion in 2020 by Persistence Market Research

The North American market is anticipated to grow from an estimated USD 5,693.4 million in 2014 to USD 9,522.2 million in 2020, growing at a CAGR of 8.9% during the forecast period.

New York, United States – July 22, 2015 /MarketersMedia/

Persistence Market Research (PMR) has released a new market study on the global biosensors market. The report, titled “Global Market Study on Biosensor: Asia-Pacific to Witness Highest Growth by 2020”, states that the global biosensors market will be valued at US$22,551.2 million in 2020, increasing from US$12,963.6 million in 2014. This amounts to growth at a moderate 9.7% CAGR from 2013 to 2020.

Technological advancements in recent years have led biosensors to be used as the analytical device of choice across various sectors, from medical diagnostics to pharmaceuticals and from the food industry to the military sector. Biosensors comprise a biological recognition unit and a transducer; while the former is capable of interacting with bio-elements such as enzymes, living tissue, and antibodies, the latter converts the changes in biomarkers into detectable electrical signals.

View Full Report With TOC: http://www.persistencemarketresearch.com/market-research/biosensor-market.asp

The increasing need for analytical information across several fields such as drug development, food safety, medical diagnosis, and environmental monitoring is driving demand for biosensors. Even though traditional laboratory techniques yield precise results, low time- and cost-efficiency, complexity, and the pre-treatment requirement of biological samples make them unsuitable for many applications.

On the other hand, the biosensor based equipment provides quick, on-site monitoring with minimum turnaround time, without any sample preparation. These devices are capable of fast detection and are best suited for applications that need quick and easy, low-cost, portable solutions.

Point-of-care testing (POCT), mainly for blood glucose monitoring, is the most proficient application area of biosensors. Biosensors provide essential information needed by physicians for timely and proper clinical management.

Request Sample Report: http://www.persistencemarketresearch.com/samples/3589

Due to its accuracy in detecting changes in specific biological markers and its fast turnaround time, biosensors are increasingly being used for cancer detection, where they provide reliable imaging of cancer cells.

Biosensors can be extremely useful to overcome global biosecurity threats such spread of chronic and infectious diseases. Furthermore, newer biosensor technologies for drug development and screening will aid the growth of the global biosensors market.

Hence, in the near future, the advent of technologically advanced noninvasive biosensors and growth of personalized medicine would offer opportunities to new entrants, which in turn will hold significant promise for this market.

Additionally, recent developments in biosensor instrumentation and use of biosensors for nanotechnology applications are also contributing to the growth of the market.

However, stringent regulatory requirements and issues pertaining to unfavorable reimbursement policies in healthcare systems hold back the global biosensors market. Additionally, increasing healthcare costs in developing nations, such as China and India, are making advanced healthcare facilities unaffordable for the common consumer.

In North America, however, increasing healthcare costs are switching the focus of patients and healthcare dispensers from hospitals to home care, which would fuel demand for biosensors in the region. However, strict regulatory and safety compliance for biosensors, which have critical applications for research laboratories, home healthcare diagnosis, point-of-care testing, security, and bio-defense may slow down the growth of the biosensors market.

Currently, the global biosensors market is highly consolidated, with only a few top organizations enjoying a monopoly in the market. However, in the coming years, many emerging biopharmaceutical companies are expected to develop superior bio-monitoring devices.

Browse Full Press Release: http://www.persistencemarketresearch.com/mediarelease/biosensor-market.asp

About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and a high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

For more information about us, please visit http://www.persistencemarketresearch.com/

Contact Info:
Name: Glen Hare
Organization: Persistence Market Research PVT. LTD.
Address: 305 Broadway, 7th floor
Phone: +1-646-568-7751

Source: http://marketersmedia.com/the-global-biosensors-market-will-be-valued-at-us23-billion-in-2020-by-persistence-market-research/87418

Release ID: 87418

Lactic and Polylactic Acid Market to be driven by Demand for Bioplastics from the Developed World: TMR

Lactic Acid Market (Food and Beverage, Personal Care, Pharmaceutical, Biodegradable Plastics and Other End-users) and Polylactic Acid Market (Packaging, Textile, Electronics, Automotive, Biomedical and Other End-users) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023

Albany, United States – July 22, 2015 /MarketersMedia/

“Global Lactic and Polylactic Acid Market to Grow Rapidly on the Back of Demand for Bioplastics from North America and Europe”

Lactic acid is one of the most commonly used industrial carboxylic acids. It is naturally found abundantly in the world and has several health benefits to humans. Nevertheless, its commercial applications are expected to rise in prominence in the next few years.

The global market for lactic and polylactic acid is expected, according to U.S.-based market intelligence firm Transparency Market Research, to reach US$3,381.8 million and US$1,358.1 million, respectively, by 2023. Both markets are expected to grow to around triple their valuation in 2014, with the lactic acid market being valued at US$1,130.4 million in 2014 and the polylactic acid market being valued at US$400.1 million. The global lactic acid market is expected to display a CAGR of 13% from 2015 to 2023, while the polylactic acid market is expected to grow at a 14.6% CAGR in the same timeframe.Here are the three main factors affecting the growth trajectory of the global lactic acid and polylactic acid markets in the said forecast period:

Browse Full Global Lactic and Polylactic Acid Market Report With Complete TOC @ http://www.transparencymarketresearch.com/lactic-poly-lactic-acid.html

Demand from Bioplastics Packaging Helping Lactic Acid and Polylactic Acid Market

The major use of lactic and polylactic acid is found in bioplastic materials used in the packaging industry; the bioplastic packaging segment held a 35% share in the lactic acid market in 2014. The rising importance of bioplastics in the packaging industry, thanks to the environmental unviability of conventional packaging materials, is, indirectly, expected to be a major growth driver for the global lactic and polylactic acid markets. Polylactic acid, in particular, has emerged as one of the most promising bioplastics currently available, giving a boost to the market. The bioplastics packaging end-use segment of the lactic acid market, meanwhile, is also expected to show a significant growth rate of 13.5% during the 2015-2023 period.

Demand for Bioplastics from the Developed World Helping Global Lactic and Polylactic Acid Market

Nor unsurprisingly, demand for bioplastic packaging materials is the highest in the developed Western World, with North America leading the regional segmentation of the global lactic acid market and Europe leading the global market for polylactic acid. Early acknowledgement of environmental issues and prompt steps taken to counter the same are helping these regional markets post booming demand for lactic and polylactic acid.

Get Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1235

Price Fluctuations in Raw Material Prices to Help Demand for Alternative Raw Materials

Due to its organic nature, lactic and polylactic acid can be obtained from natural means, such as sugar, corn, rice, etc. It can also be produced through synthetic means, utilizing petrochemicals. Particularly in the case of the latter, the instability in the price structure of the market, due to various geopolitical and economic issues, is hampering the growth prospects of the lactic and polylactic acid markets. Even though natural sources of lactic and polylactic acid represents a viable option in the short-to-medium term, long-term production of the two acids is still clouded over by price fluctuations in the oil and gas industry. Due to this, alternative raw materials for the production of lactic and polylactic acid are expected to rise to the fore in the aforementioned forecast period.

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr.Nachiket Ghumare
90 State Street Suite 700
Albany NY 12207
Tel: +1-518-618-1030
USA Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

For more information about us, please visit http://www.transparencymarketresearch.com/lactic-poly-lactic-acid.html

Contact Info:
Name: Mr. Nachiket
Email: sales@transparencymarketresearch.com
Organization: Transparency Market Research
Address: State Tower, 90 State Street,
Phone: 15186181030

Source: http://marketersmedia.com/lactic-and-polylactic-acid-market-to-be-driven-by-demand-for-bioplastics-from-the-developed-world-tmr/87416

Release ID: 87416

Active Pharmaceutical Ingredients (API) Market Expected to Reach USD 185.9 billion Globally in 2020: Transparency Market Research

Active Pharmaceutical Ingredients (API) Market: (Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured, by Geography, and by Therapeutic Area) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020

Albany, United States – July 22, 2015 /MarketersMedia/

According to a new market report published by Transparency Market Research “Active Pharmaceutical Ingredients (API) Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020,” the global active pharmaceutical ingredients market was valued at USD 119.7 billion in 2013 and is anticipated to reach USD 185.9 billion by 2020, expanding at a CAGR of 6.5% during the forecast period from 2014 to 2020.

According to the World Health Organization (WHO), in 2012, cancer was among the leading causes of morbidity and mortality worldwide, with approximately 14 million newly diagnosed cases and 8.2 million cancer-related deaths. Therefore, the oncology segment is expected to be fastest growing segment in the global API market. Moreover, most of the drugs in this segment contain High Potency Active Pharmaceutical Ingredients (HPAPIs) which itself is a rapidly growing segment in the global API market. The market growth of this segment will be particularly higher than other segments owing to loss of patent protection for blockbuster drugs such as Herceptin (Roche), Arimidex (AstraZeneca), Xeloda (Roche), Abraxane (Celgene), Temodar (Merck & Co.) and Vidaza (Celgene) between 2010 and 2014.

The global active pharmaceutical ingredients market is segmented on the basis of therapeutic area into non-steroidal anti-inflammatory drugs (NSAIDS), oncology drugs, anti-diabetic drugs, cardiovascular drugs, central nervous system drugs, musculoskeletal drugs, and others. The overall API market is expected to witness substantial growth during the forecast period from 2014 to 2020, wherein oncology and central nervous system drugs segments would play a vital role. These segments are expected to grow at the highest CAGR during the forecast period from 2014 to 2020. Cardiovascular drugs accounted for the largest market revenue share in 2013 due to the rising prevalence of cardiovascular diseases, sedentary lifestyle, and aging population. Bestselling products losing market exclusivity has been a common trend in all market segments, thus creating opportunities for generic products. This in turn increases the demand for APIs in particular therapeutics segments.

Browse the full Active Pharmaceutical Ingredients (API) Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020 report at http://www.transparencymarketresearch.com/active-pharmaceutical-ingredients.html

Currently, biological drugs are gaining importance in the treatment of chronic diseases such as cancer and diabetes. These drugs are costlier due to challenging set of manufacturing requirements and difficult replication as against chemical APIs. Advancements in the production technology have enabled production of biosimilars that are not exact copies of innovator drugs, but highly comparable in terms of safety and efficacy. Europe has been the frontrunner in approving biosimilars, and the WHO has also set guidelines on similar lines of those set by the European Union. Regulatory pathways in the biosimilars space in different nations are evolving and this implies a great market opportunity ahead for the biopharmaceutical companies. Approval of the first biosimilar in the U.S. for filgrastim (2015) indicates opening up of the highly regulated U.S. market, which would further push the overall API market growth.

Major players competing in this market include Boehringer Ingelheim Group, Cambrex Corporation, Dr. Reddy’s Laboratories, Ltd., BASF SE, Hospira, Inc., Lonza Group, Mylan, Inc., Novartis AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Actavis plc, and Wuxi Apptec.

Get Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1690

The Global Active Pharmaceutical Ingredients Market is segmented as follows:

Active Pharmaceutical Ingredients Market, by Type of Manufacturing
– Captive or In-house API manufacturing
– API contract manufacturing

Active Pharmaceutical Ingredients Market, by Type of API
– Synthetic Chemical API
– Biological API

Active Pharmaceutical Ingredients Market, by Type of Drug
– Branded or Innovative Prescription Drugs
– Generic Prescription Drugs
– Over-the-counter Drugs

Active Pharmaceutical Ingredients Market, by Therapeutic Area
– Non-steroidal Anti-inflammatory Drugs (NSAIDs)
– Oncology Drugs
– Anti-diabetic Drugs
– Cardiovascular Drugs
– Central Nervous System Drugs
– Musculoskeletal Drugs
– Other Drugs (antibacterial, antiviral, antifungal, etc.)

Active Pharmaceutical Ingredients Market, by Geography
– North America
– Europe
– Asia Pacific
– Rest of the World (RoW)

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

For more information about us, please visit http://www.transparencymarketresearch.com/active-pharmaceutical-ingredients.html

Contact Info:
Name: Mr. Nachiket
Email: sales@transparencymarketresearch.com
Organization: Transparency Market Research
Address: State Tower, 90 State Street,
Phone: 15186181030

Source: http://marketersmedia.com/active-pharmaceutical-ingredients-api-market-expected-to-reach-usd-185-9-billion-globally-in-2020-transparency-market-research/87420

Release ID: 87420

Sugarmade Enters LOI with Boa Coc Paper for Accretive Acquisition

CITY OF INDUSTRY, CA / ACCESSWIRE / July 22, 2015 / Sugarmade, Inc. (OCTQB:SGMD), a supplier of environmentally friendly tree free office paper made from sugarcane waste and bamboo and custom printed paper supplies to the restaurant industry, today announced its intent to acquire Bao Coc International Paper & Plastic, LTD, a manufacturer of high-grade postconsumer paper products. Sugarmade expects the acquisition, which is pending the completion of mutual due diligence and an injection of capital by Sugarmade into Bao Coc, to be accretive to the Company’s revenues and earnings.

“We plan to fully integrate this Vietnamese operation into Sugarmade as we believe it fits well into our increasingly environmental friendly product portfolio. Additionally, it will increase both our revenue growth and earnings. We have also entered into negotiations for at least two other accretive acquisitions, which will add further to our corporate growth and development,” commented Jimmy Chan, CEO of Sugarmade.

Sugarmade expects to realize approximately $800,000 to $1 million of new revenue and positive cash flow from the Bao Coc acquisition over the 12-month period subsequent to the closing of the transaction. Several new products are currently being planned under the Bao Coc umbrella, which are expected to further boost both revenues and earnings of the operation. Management of the Company believes there are certain synergies to be gained by the integration of Bao Coc into the Company, including, but not limited to, costs savings relative to trans-pacific container shipments, increased purchasing power and improved leverage of management talent across multiple operations.

Bao Coc International Paper & Plastic, LTD is at the cutting edge of the rapidly evolving environmental and sustainability movement within Southeast Asia. The Company utilizes virtually 100% recycled paper in its manufacturing processes yielding a paper product that is not only high quality, but also friendly to the environment. These products are then shipped to the United States for use mainly in the fast food industry under long-term contracts and commitments.

About Sugarmade, Inc. (OTC:SGMD)

Sugarmade, Inc., (OTC:SGMD) is a City of Industry, California-based, publicly traded company engaged in a variety of business operations, including advertising-supported printed materials for the restaurant and takeout industries, generic and custom printed products for these same industries, and environmentally friendly tree free office and copy paper. Sugarmade also holds a minority stake in several patents relating to the seasoning of food products. For more information on Sugarmade please visit us at www.Sugarmade.com or at www.CarryOutSupplies.com.

Contract Information:

For media and press or investor inquiries, please contact the Company at info@SugarMade.com or Katherine Zuniga at (888) 880-0081.

SOURCE: Sugarmade, Inc.

ReleaseID: 430772

Washington Tractor to Tell Their Brand and Customer Stories Through Video Storytelling

The Video Looks to Capture the Heart of Washington Tractor’s Transformation from a One-store Operation to a Premier John Deere Dealer Group with 12 Locations that Spans Four Generations

QUINCY, WA / ACCESSWIRE / July 22, 2015 / Washington Tractor, the premiere John Deere dealer group with 12 convenient locations throughout Washington State, announced that they hired legendary storytelling videographer Charley Voorhis to tell the history of the company. The video will capture the essence of the company and how it transformed from a one-store operation into a multi-location John Deere dealership.

“We’re excited about our new relationship with Washington Tractor because farmers are the backbone of our country, and Washington Tractor has established themselves as a significant player in the farming industry statewide,” said Charley Voorhis, owner of Voortex Productions. “Washington Tractor pairs their devotion to quality products and outstanding customer service with our style of authentic storytelling which will help awaken a sense of connection and pride for both employees and customers alike.”

Washington Tractor was established in November 2010 when three, family-owned and operated John Deere dealers merged. Over the next three years, Washington Tractor would merge with and acquire other locations to become a five-family company.

“Our history, employees and customers have shaped us into the company we are today,’ said Rick Hirai, COO of Washington Tractor. “I believe storytelling is a highly effective form of human connection, and we are confident that Charley and his team are the perfect fit to unify our team under one vision while also communicating to our local communities and customer’s how much we value our relationships over the years.”

According to the website, Washington Tractor has worked hard to preserve their single-store identities and strong customer relationships. Their goals are to provide an enhanced product selection that includes the iconic outdoor brands John Deere, Honda and Stihl, offer outstanding customer service and employee expertise as well as competitive pricing.

Washington Tractor has 12 locations: Quincy, Ellensburg, Lynden, Sumner, Okanogan, Olympia, Chehalis, Aberdeen, Poulsbo, Mount Vernon, Snohomish, and Yakima.

The company features new and pre-owned equipment for commercial, residential and agricultural needs. These include new tractors and farm equipment, riding lawn mowers, outdoor power equipment, construction equipment and tractor attachments.

About Washington Tractor

Washington Tractor is a premiere John Deere dealer group with 12 convenient location’s throughout Washington State that provides full service parts, sales, equipment service, and ongoing support during the lifecycle of customers’ tractors, combines, riding lawn mowers, hay and forage equipment, and outdoor power equipment. For more information, please visit http://www.washingtontractor.com.

Contact:

Tyler Musson
tmusson@washingtontractor.com
509-787-4553

SOURCE: Washington Tractor

ReleaseID: 430769

SeeThruEquity Initiates Coverage on BioCorRx Inc. with a Price Target of $0.13

NEW YORK, NY / ACCESSWIRE / July 22, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage of BioCorRx Inc. (OTCQB: BICX) with a Price Target of $0.13.

The report is available here: BICX Initiation Report. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack’s. The report will be available on these platforms. The firm also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.

With headquarters in Santa Ana, CA, BICX distributes and licenses the Start Fresh Program for alcoholism and opioid addiction to a growing network of clinics and addiction treatment centers across the country. BICX has begun to experience accelerating business trends of late, with the number of treatment centers that offer the Start Fresh Program(R) more than doubling over the last six quarters, which has also been a catalyst for rapid revenue growth. Indeed, since a rebranding of the company and a focus on growing by finding licensing and distribution partners, BICX has seen its top line rising quickly. Revenues grew by 111% YoY in 1Q15 after growing more than 60% from 2013 to 2014. We expect the company to continue these trends in 2015E, and view BICX as an intriguing, high risk / high reward enterprise in the specialized services subcategory of the health care industry.

“Given the multi-billion dollar market opportunity and even larger economic cost of treating alcohol and opioid substance abuse, as well as the lack of effective treatments in the current medical paradigm, we see a large opportunity for BICX as the company expands. With limited resources deployed to date, the company has more than doubled the number of clinics offering the Start Fresh Program in the last year while the number of patients undergoing the Start Fresh Program(R) treatment plan has risen by 402%. Considering the opportunity and apparent early traction garnered by the company, we see BICX as an intriguing, high risk / high reward enterprise in the specialized services subcategory of the health care industry.,” commented Ajay Tandon, CEO of SeeThruEquity. “We are initiating coverage with a 12-month price target of $0.13 per share.”

Additional highlights from the report are as follows:

Start Fresh Program achieving growing momentum

BICX has begun to experience accelerating business trends of late, with the number of licensed and contracted treatment centers offering the Start Fresh Program(R) more than doubling over the last six quarters, which has also been a catalyst for rapid revenue growth. Indeed, since a rebranding of the company and a focus on growing by finding licensing and distribution partners, BICX has seen its top line rising quickly with high margin revenue. Revenues grew by 111% YoY in 1Q15 after growing more than 60% from 2013 to 2014 – a year in which the company generated positive operating cash from operations. We expect BICX to continue its strong top line growth in 2015E as the company benefits from direct marketing efforts that spread awareness of the Start Fresh Program through campaigns in social media, TV, PR, and patient testimonials.

Alcoholism and opioid treatment a large and fragmented market

BICX’s Start Fresh Program(R) is a unique and proprietary approach to provide treatment for alcoholism and opioid addiction – two large and fragmented markets with ample room for growth and expansion. According to the Center for Diseases Control (CDC) there are over 38mn heavy drinkers in the United States. Indeed, the estimated market size for alcohol treatment is $22Bn per year, and the economic impact from heavy drinking is estimated at over $230Bn. Similarly, there are over 2mn Americans suffering from opioid addiction. There is a natural overlapping of end market applications for the Start Fresh Program(R), as opioids account for 18% alcohol treatment facility admissions.

Please review important disclosures on our website at www.seethruequity.com.

About BioCorRx, Inc.

BioCorRx, Inc.(R) (OTCQB: BICX) is an addiction treatment and rehabilitation company offering a unique approach to the treatment of substance abuse addiction. The Start Fresh Program(R), a medication-assisted treatment program, consists of two components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions. Clinic reports show that the treatment program can be successful for individuals who complete the program.

About SeeThruEquity

SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The research is not paid for and is unbiased. The company does not conduct any investment banking or commission based business. SeeThruEquity is approved to contribute its research to Thomson One Analytics (First Call), Capital IQ, FactSet, Zacks, and distribute its research to its database of opt-in investors. The company also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.

For more information visit www.seethruequity.com.

Contact:

Ajay Tandon
SeeThruEquity
info@seethruequity.com

SOURCE: SeeThruEquity

ReleaseID: 430766

Pacific Green Technologies Appoints CEO Asia

SAN JOSE, CA / ACCESSWIRE / July 22, 2015 / Pacific Green Technologies Inc. (“the Company”) (OTCQB: PGTK), is pleased to announce the appointment of Alex Shead to the board of the Company as CEO of the Company’s Asia division after a year of leading the company’s expansion into China and the broader Asian region.

Alex has a 25-year track record of creating shareholder value through M&A activity. With a wide range of entrepreneurial experience focused principally in financial services, Alex has led over 30 business acquisitions and developed an in-depth knowledge of large-scale company purchases and operational integrations.

As an entrepreneur CEO, Alex has been a founder of numerous businesses including Stuart Alexander in the UK and Mecon Winsure in Australia both of which were sold to public quoted companies. Alex has been the Responsible Officer with both the Australian Securities and Investments Commission and Lloyd’s of London.

In 2008 Alex conceived an award winning and environmentally sustainable International NGO, Food Ladder, resulting in 9 social enterprises that have culminated in the delivery of 400 jobs to people previously suffering from long-term unemployment and disadvantage. 

Neil Carmichael, Chief Executive of the Company, commented, “I am delighted to welcome Alex to the board of the Company as CEO Asia. He has a fine track record in building businesses and realising value for shareholders which will be critical in helping us realise our ambitions in the region.”

Alex Shead, Managing Director and CEO for Asia, commented, “I am very pleased to join the board of the Company and continuing to spearhead the commercialisation of the Company’s technologies in Asia.”

Biography:

Alexander Mark Shead was born in 1961 and is a British, Australian and Swiss national. He was educated at Harrow School in England and the Sorbonne University in Paris. In 1993 he co-founded Stuart Alexander in the UK, an insurance advisory business which he sold to AXA UK. In 2004, Alex moved to Australia where he was a cornerstone investor and Director of Milne Alexander, a boutique insurance broking and advisory firm until it’s sale in 2007. Between 2007 and 2014 he was Executive Chairman of the Mecon Winsure Insurance Group until its sale to Steadfast Group Limited in 2014. 

In 2008, Alex founded Food Ladder, an award winning International NGO established to create financially sustainable social enterprises that empower disadvantaged individuals through employment. Alex remains a Director of Food Ladder. In 2009 he was a Director of First Unity Financial Group, a wealth management business that was sold in 2011. In 2012 he became and still remains Non-Executive Chairman of Lockton Companies Australia, the Australian arm of Lockton, the world’s largest privately owned, independent insurance brokerage firm.

About Pacific Green Technologies, Inc.

Pacific Green Technologies Inc. is focused on addressing the world’s need for cleaner and more sustainable energy. PGT is divided into three divisions:

– the design, development, licensing and marketing of numerous types of technologies designed to improve the environment through clean energy use;

– the development of renewable power plants; and

– licensing its proprietary emission control technologies, ENVI-Clean(TM) and ENVI-Pure(TM), to power stations worldwide.

For more information, visit the Company’s website: www.pacificgreentechnologies.com.

Notice Regarding Forward-Looking Statements:

This news release contains “forward-looking statements,” as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this news release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the Company’s expansion into Asia and/or the commercialisation of the Company’s technologies in the region.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, general economic conditions, and our ability to enter into the requisite agreements and arrangements in Asia. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this news release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

CONTACT:

Neil Carmichael, President and Director
Pacific Green Technologies
T: +1 (408) 538-3373

SOURCE: Pacific Green Technologies Inc.

ReleaseID: 430771

Kiska Exploration Update

VANCOUVER, BC / ACCESSWIRE / July 22, 2015 / Kiska Metals Corporation (“Kiska” or the “Company”) is pleased to announce its current and upcoming exploration activities for the 2015 season, and the signing of two new exploration alliances. “Kiska continues to execute the Prospect Generator business model by having top-tier mining companies drill and explore our projects this season, such as Kliyul and Copper Joe,” stated Kiska’s President Grant Ewing. “In these challenging market conditions, Kiska stands out by incorporating innovative exploration alliances and new targeting technologies that aim to improve the odds of discovery, optimize exploration expenditures, and generate quality exploration opportunities to feed the industry’s diminishing pipeline, all while continuing to reduce the company’s burn rate.”

Highlights include:

– Partner-funded drilling and geophysical surveys at the Kliyul porphyry project in north-central BC by Teck Resources Limited (“Teck”) has commenced.
– Geophysical survey and infill mapping completed at the Copper Joe porphyry project in south-central Alaska, funded by First Quantum Minerals.
– A recently signed Alliance with BW Mining to generate Neural Network targets in the prolific Abitibi gold belt in Ontario and Quebec, and the Quesnel porphyry belt in BC.
– A recently signed Alliance with Fathom Geophysics to utilize and develop a new and proprietary geochemical technique to target porphyry systems under cover and at depth.
– Assessing potential partners on Kiska’s Chuchi copper-gold porphyry project, a road-accessible property with proven porphyry mineralization and exploration upside in north-central BC.
– Recently completed geological mapping and property-wide soil sampling at Kiska’s Midlothian gold project in Ontario to define drill targets.
– Property evaluations of early- to advanced-stage projects to potentially add new projects to the portfolio.

Partnered Projects:

Kliyul

Kliyul is a copper-gold porphyry project located 67 kilometres southeast of the past-producing Kemess Mine in north-central British Columbia and lies adjacent to the Kemess Mine access road and power line. The Company owns a 100% interest in the 6,537 hectare property subject to a 1.5% NSR. Exploration is being funded by Teck as part of an earn-in agreement whereby Teck can earn a 51% interest in the Property by incurring cumulative aggregate expenditures of $5.5 million on or before January 31, 2018, and up to a 65% interest by incurring additional expenditures of $6.5 million ($12 million total) on or before January 31, 2021. To date, Teck has spent approximately $765,000 in exploration and is currently planning to drill 1300 metres in 2 to 3 drillholes to test the main Kliyul Zone and to conduct approximately 20 line-kilometres of Induced Polarization geophysics over other geological and geochemical targets on the Property. The program is now underway.

Copper Joe

Copper Joe is a copper-gold-molybdenum porphyry project located in the Alaska Range 175 kilometers northwest of Anchorage. Exploration on the property is being funded by First Quantum Minerals as part of an earn-in agreement. First Quantum can earn an initial 51% interest in the Copper Joe Project by funding expenditures of US$5,000,000 by December 31, 2017, and 80% upon a production decision, with Kiska retaining a 20% carried interest. First Quantum recently completed a geological mapping program and a Magnetotelluric geophysical survey on the property and has spent approximately $826,000 prior to this work. The results of this work are currently being evaluated to determine the potential of a follow-up drill program.

Innovative Exploration Alliances:

Kiska has entered into an exclusive Alliance agreement with BW Mining to initiate Neural Network targeting studies in the Abitibi gold belt of Ontario and Quebec, and the southern Quesnel porphyry belt in British Columbia. BW Mining is a pioneer in the application of Neural Networks for targeting base and precious metal deposits. Neural Networks provide a cost-effective exploration advantage by integrating numerous exploration datasets (i.e. geology, geochemistry, geophysics, satellite), producing unbiased targets based on the signatures of known deposits, significantly leveraging public and private geoscience data and dollars, quickly and efficiently reducing the exploration search space, and targeting in areas with challenging overburden cover. Kiska is currently seeking partners to participate in the Neural Network targeting.

Kiska has entered into an alliance agreement with Fathom Geophysics for the exclusive rights to a proprietary method for evaluating and targeting porphyry systems in 3D based on trace element abundances and zonation in surface rock samples and/or drill core. This computational method utilizes the concentration and spatial distribution of key trace elements in the porphyry environment. This method has the potential to target and evaluate porphyry systems efficiently and with less drilling, therefore reducing the discovery timeline and cost. Kiska is currently seeking partners who wish to test this method on known systems, and to apply the method in an Exploration Alliance.

Negotiations Underway Regarding Partnership: Chuchi

Kiska has conducted and is currently planning additional tours with potential partners on the Chuchi Property. The Chuchi Property hosts a 12 km2 propylitic alteration zone that is centred on a drill-proven copper-gold porphyry system in a highly prospective region of the Quesnel porphyry belt in north-central British Columbia. The road-accessible property occurs in gentle topography just 32 km from the Mt. Milligan copper-gold mine. Previous drilling in the early 1990’s returned significant copper-gold mineralization (the “BP Zone”) that is open in multiple directions.

Advancing Projects: Midlothian

Kiska recently completed a geological mapping program and a property-wide MMI soil geochemical survey at the Midlothian Project, Ontario, in order to advance the project and identify drill targets. The Midlothian Project is a road-accessible lode gold project located in Ontario’s Abitibi Greenstone Belt and occurs 25 km west of the Young-Davidson gold mine. The property is transected by an under-explored segment of the Cadillac-Larder Lake Fault Zone, host to the prolific gold camps in the region.

The technical content of this document was reviewed and approved by Michael Roberts, Ph.D., P.Geo., Vice President of Exploration for Kiska Metals Corporation, a Qualified Person as defined by National Instrument 43-101.

About Kiska Metals Corporation

Kiska Metals Corporation is a prospect generator company with a high quality portfolio of gold and copper projects throughout North America. Two of Kiska’s projects are held under option agreements with major mining companies. Kiska has several other gold and copper projects available for option-joint venture as well as extensive databases and a royalty portfolio.

On behalf of Kiska Metals Corporation

“Grant Ewing”
Grant Ewing, President & CEO


Contact:

575-510 Burrard St. Vancouver, BC, Canada V6C 3A8
Tel: 604.669.6660 Fax: 604.669.0898
http://www.kiskametals.com
TSX-V: KSK
Contact: Brian Miller or Grant Ewing

Neither TSX Venture Exchange nor its Regulation Services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


CAUTIONARY STATEMENT:
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. This News Release includes certain “forward-looking statements.” Other than statements of historical fact, all statements included in this release, including, without limitation, statements regarding future plans and objectives of Kiska Metals Corporation, are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Kiska’s expectations are the risks detailed herein and from time to time in the filings made by Kiska Metals Corporation with securities regulators. Those filings can be found on the Internet at http://www.sedar.com.

SOURCE: Kiska Metals Corporation

ReleaseID: 430749

Greenfield Farms Food Responds to Shareholder Inquiries

WEST PALM BEACH, FL / ACCESSWIRE / July 22, 2015 / Greenfield Farms Food, Inc. (Greenfield or the Company) (PINKSHEETS: GRAS) is providing clarification today in response to shareholder inquiries regarding SEC civil litigation of third party defendants in which the Company is mentioned. It is important to note neither the Company nor any of its officers or directors are plaintiffs in this lawsuit; and all activities for which the Company is mentioned occurred in 2011 prior to current management taking control of the Company. Neither the Company nor its management team know the plaintiffs or have any knowledge or information regarding the allegations contained therein. Accordingly, neither the Company nor its management can provide any further information regarding this lawsuit in which they are not parties.

About Greenfield Farms Food, Inc.

Greenfield is a publicly-traded, nominally capitalized company, operating through its wholly-owned subsidiary Carmelas Pizzeria CO, Inc. Carmelas Pizzeria restaurants includes pizza buffets, alcohol service, delivery and carry-out, depending on the location.

About Carmelas Pizzeria

Carmela’s Pizzeria presently has four Dayton, Ohio area locations offering authentic New York style pizza. Carmela’s offers a full service menu for Dine In, Carry out and Delivery as well as pizza buffets in select stores. Carmela’s has been noted in the Dayton Daily News as one of “The Best Pizzerias” in Dayton. Visit the Carmela’s website at: http://www.CarmelasOhio.com/.

Safe Harbor for Forward-looking Statements

This news release may contain forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the companys progress, business opportunities and growth prospects, they are based on managements current beliefs and assumptions as to future events. However, since the companys operations and business prospects are always subject to risk and uncertainties, the forward-looking events and circumstances discussed in this news release might not occur, and actual results could differ materially from those described, anticipated or implied. For a more complete discussion of such risks and uncertainties, please refer to the company’s filings with the Securities and Exchange Commission.

Contact Information:

Greenfield Farms Food, Inc.
Henry Fong, CFO
(561) 514-9042

SOURCE: Greenfield Farms Food, Inc.

ReleaseID: 430747

Lithium Exploration Group Updates Shareholders on Stress-Testing of Ultrasonic Generator

PHOENIX, AZ /ACCESSWIRE / July 22, 2015 / Lithium Exploration Group Inc. (PINKSHEETS: LEXG), announced today that stress-testing of the SonCav unit is continuing in Dallas, TX through the month of August. The company reported in June on the successful testing of both the water unit and the oil unit at the manufacturer’s facility in Dallas. The water unit testing began in May and, after running the unit for a number of weeks, the unit was disassembled and inspected for wear and tear. The water unit is being put back together now and stress-testing should resume next week. The oil unit was also successfully tested at the facility in June using fresh water, to ensure that there were no issues with the unit after the over-the-road accident in February.

“It is fantastic that both units are in play right now. Final design of the oil unit skid is taking place at this moment and we hope to have it shipped to Alberta for field-testing soon. I had hoped to have it in Alberta in July, but it is taking a bit longer than expected to get the design work done and the unit out the door,” commented CEO Alex Walsh. “The beauty is that both units are in good working order and, while we are experiencing a slight delay in field-testing the oil unit, the water unit will continue to stress-test and gather performance data, thus helping the overall effort of commercialization.”

About Lithium Exploration Group

Lithium Exploration Group is a US-based exploration and development company focused on the acquisition and development potential of lithium brines and other precious metals that demonstrate high probability for near-term production. Currently the company is focused on its Western Canada lithium assets, testing its Ultrasonic Generator Technology and the acquisition of oil and gas related assets in Western Canada. Lithium Exploration Group is a fully reporting company traded on the OTC Markets under the symbol LEXG. Website: www.lithiumexplorationgroup.com.

Safe Harbor Statement

This news release contains “forward-looking statements”. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future testing of the ultrasonic technology.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration and difficulties associated with obtaining financing on acceptable terms. We are not in control of lithium prices and these could vary to make development uneconomic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements.

Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

CONTACT:

Shanon Chilson
480-641-4790
info@lithiumexplorationgroup.com

SOURCE: Lithium Exploration Group Inc.

ReleaseID: 430765